Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.61 USD
32.83 M USD
216.07 M USD
19.83 M
About Shin Nippon Biomedical Laboratories, Ltd.
Sector
CEO
Ryoichi Nagata
Website
Headquarters
Tokyo
Founded
1957
IPO date
Mar 8, 2004
Identifiers
2
ISIN JP3379950003
Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. Its operations are carried out through the following segments: CRO Business, Translational Research Business, Medipolis Business, and Others. he CRO business is a business that verifies the efficacy and safety of test substances created by clients such as pharmaceutical companies using laboratory animals, cells, and bacteria. The Translational Research Business segment utilizes drug and device development capabilities to accelerate drug development which leads to out-licensing to pharmaceutical companies. The Medipolis Business segment deals with the property management and geothermal power generation businesses. The Others segment engages in the information collection in Europe, which includes real estate and environmental equipment operations. The company was founded in April 1957 and is headquartered in Tokyo, Japan.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SBLOF is 10.03 USD — it has decreased by −20.22% in the past 24 hours. Watch Shin Nippon Biomedical Laboratories Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Shin Nippon Biomedical Laboratories Ltd. stocks are traded under the ticker SBLOF.
We've gathered analysts' opinions on Shin Nippon Biomedical Laboratories Ltd. future price: according to them, SBLOF price has a max estimate of 21.80 USD and a min estimate of 21.80 USD. Watch SBLOF chart and read a more detailed Shin Nippon Biomedical Laboratories Ltd. stock forecast: see what analysts think of Shin Nippon Biomedical Laboratories Ltd. and suggest that you do with its stocks.
SBLOF reached its all-time high on May 16, 2023 with the price of 16.97 USD, and its all-time low was 9.36 USD and was reached on Apr 25, 2025. View more price dynamics on SBLOF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SBLOF stock is 25.35% volatile and has beta coefficient of 0.86. Track Shin Nippon Biomedical Laboratories Ltd. stock price on the chart and check out the list of the most volatile stocks — is Shin Nippon Biomedical Laboratories Ltd. there?
Today Shin Nippon Biomedical Laboratories Ltd. has the market capitalization of 469.21 M, it has increased by 4.77% over the last week.
Yes, you can track Shin Nippon Biomedical Laboratories Ltd. financials in yearly and quarterly reports right on TradingView.
Shin Nippon Biomedical Laboratories Ltd. is going to release the next earnings report on May 11, 2026. Keep track of upcoming events with our Earnings Calendar.
Shin Nippon Biomedical Laboratories Ltd. revenue for the last quarter amounts to 41.02 M USD, despite the estimated figure of 66.57 M USD. In the next quarter, revenue is expected to reach 62.20 M USD.
SBLOF net income for the last quarter is 7.72 M USD, while the quarter before that showed 5.41 M USD of net income which accounts for 42.61% change. Track more Shin Nippon Biomedical Laboratories Ltd. financial stats to get the full picture.
Shin Nippon Biomedical Laboratories Ltd. dividend yield was 3.49% in 2024, and payout ratio reached 42.27%. The year before the numbers were 3.29% and 37.63% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 1.44 K employees. See our rating of the largest employees — is Shin Nippon Biomedical Laboratories Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Shin Nippon Biomedical Laboratories Ltd. EBITDA is 33.91 M USD, and current EBITDA margin is 17.27%. See more stats in Shin Nippon Biomedical Laboratories Ltd. financial statements.
Like other stocks, SBLOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Shin Nippon Biomedical Laboratories Ltd. stock right from TradingView charts — choose your broker and connect to your account.